The U.S. Food & Drug Administration regulates new drug approvals in a process that is extremely thorough, lengthy and expensive. Regulations apply to a drug candidate’s product development phase, the approval process and after approval. Failure to comply could have serious business and financial con-sequences to a biotech venture, including the FDA’s refusal to approve…

Many biotech ventures begin life as an invention conceived by a scientist/professor working in a laboratory at a federally-funded university or scientific institute. The intellectual property underlying such inventions is owned by the academic institution, a potentially valuable asset to be nurtured. Since enactment of the Bayh-Dole Act in 1980, academic institutions through their technology…

Rimon’s Managing Partners Michael Moradzadeh and Yaacov Silberman will discuss innovation and disruption in the law firm space at The Center on the Legal Profession Stanford Law School. They will discuss the history of innovation in the traditional legal marketplace, the current landscape as alternative models have rapidly increased their presence, and their own path…

How common it is to hear groans and complaints in the startup sector of the U.S. life sciences industry about the extreme difficulty facing entrepreneurs who are trying to finance the launch, development and growth of a drug discovery venture. We hear that angel investors – both individuals and funds — lack interest in investing…

New York, NY (February 11, 2014) Rimon, P.C. has added Timothy M. Gladden, a transactional attorney who has handled hundreds of deals for early stage and middle market companies, as a partner in its New York office. Mr. Gladden joins Rimon from Gladden Legal Group. Prior to that, he co-led the emerging companies practice at Schnader Harrison Segal &…

View Online Version Building Enterprise Value Seminar Series Laying the Foundation Thursday, January 23, 2014 7:30 a.m. – 9:30 a.m. Free Seminar | CPE credit available Golden Gate University, 536 Mission Street San Francisco, CA 94105 This event will also be webcast Join us as we kick off a series of events on Building Enterprise Value, including panel discussions, roundtables,…

On July 10, the SEC adopted a new rule lifting the ban on general solicitations and advertising for broker-dealers and for hedge fund and private equity fund offerings. This is a significant change from existing law and allows a fund to make its website more accessible to the public, to use social media, and to…

Mandatory trade reporting under EMIR is scheduled to begin on February 12th, 2014. ISDA and the FOA have published the “EMIR Reporting Delegation Agreement” (the “Delegation Agreement”) which provides the OTC Derivatives market industry with a tool to document delegated reporting arrangements. The Delegation Agreement generally contemplates that one party (generally the swap dealer) will…

EXECUTIVE SUMMARY: With the maximum California state income tax rate at 13.3% for both ordinary income and capital gain, strategies to defer or eliminate California state income tax have greater importance. One strategy to consider is the creation of an irrevocable children’s trust in a state with no state income tax. If the trust is…